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Background: Since 2011, the level of pyrethroid resistance in the major malaria mosquito, Anopheles coluzzi, has
increased to such an extent in Burkina Faso that none of the long lasting insecticide treated nets (LLINs) currently
in use throughout the country kill the local mosquito vectors. We investigated whether this observed increase was
associated with transcriptional changes in field-caught Anopheles coluzzi using two independent whole-genome
microarray studies, performed in 2011 and 2012.
Results: Mosquitoes were collected from south-west Burkina Faso in 2011 and 2012 and insecticide exposed or
non-exposed insects were compared to laboratory susceptible colonies using whole-genome microarrays. Using
a stringent filtering process we identified 136 genes, including the well-studied detoxification enzymes (p450
monoxygenases and esterases) and non-detoxification genes (e.g. cell transporters and cuticular components),
associated with pyrethroid resistance, whose basal expression level increased during the timeframe of the study.
A subset of these were validated by qPCR using samples from two study sites, collected over 3 years and marked
increases in expression were observed each year. We hypothesise that these genes are contributing to this rapidly
increasing resistance phenotype in An. coluzzi. A comprehensive analysis of the knockdown resistance (kdr) mutations
(L1014S, L1014F and N1575Y) revealed that the majority of the resistance phenotype is not explained by target-site
modifications.
Conclusions: Our data indicate that the recent and rapid increase in pyrethroid resistance observed in south-west
Burkina Faso is associated with gene expression profiles described here. Over a third of these candidates are also
overexpressed in multiple pyrethroid resistant populations of An. coluzzi from neighbouring Côte d’Ivoire. This suite of
molecular markers can be used to track the spread of the extreme pyrethroid resistance phenotype that is sweeping
through West Africa and to determine the functional basis of this trait.
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Resistance to the pyrethroid insecticides in Anopheles
malaria mosquito vectors is now widespread throughout
Sub-Saharan Africa [1]. The recent gains in reducing the
burden of malaria, achieved largely by the scale-up of
long lasting insecticide treated nets (LLINs), are under
threat as pyrethroids represent the only insecticide class
approved for use on LLINs.
The south-west of Burkina Faso was one of the first
regions to report pyrethroid resistance in the local mal-
aria vector population [2]. Since the late 1990s the level
of resistance has gradually increased with the intensive
agricultural activity in the area a likely contributing fac-
tor [3,4]. A recent survey of resistance in the village of
Vallée du Kou in the south-west of the country, con-
ducted between 2011 and 2013, has highlighted the scale
of the problem with resistance levels of over 1000-fold
described [5]. Laboratory assays found that none of the
LLINs currently used throughout the country gave ac-
ceptable levels of mortality against local mosquitoes,
raising serious concerns over the efficacy of current vec-
tor control strategies in the country.
The main resistance mechanisms to pyrethroids include
target site mutations in the voltage sodium channel (the
knockdown resistance mutations (kdr), L1014F, L1014S
and N1575Y) and metabolic resistance including the over-
expression of the three major detoxification enzyme
families (p450 monooxygenases (p450s), glutathione-S-
transferases (GSTs) and the carboxylesterases) (reviewed
in [6]). While the rise and spread of the kdr alleles in
Anopheles gambiae throughout Sub-Saharan African are
undoubtedly associated with DDT and pyrethroid resist-
ance, they do not account for all of the variation in the
phenotype [7,8].
The design of microarray-based platforms for charac-
terising gene expression profiles in Anopheles gambiae,
initially based on detoxification enzymes [9], and more
recently, using whole-genome wide arrays [10], has pro-
vided evidence for specific genes contributing to insecti-
cide resistance in wild-caught An. gambiae (e.g. [11-13]).
Commonly over-expressed genes have been identified in
independent studies across Sub-Saharan Africa includ-
ing, for example, specific P450 enzymes (e.g. CYP6M2
and CYP6P3) which have been shown to metabolize
pyrethroids and other insecticide classes [10,12,14-16].
Most of these transcription studies conducted to date
have compared resistant mosquitoes, collected at a sin-
gle time point, to either sympatric non-exposed insects
or laboratory susceptible strains. Few studies have fol-
lowed transcriptional changes in wild-caught An. gam-
biae, from a single origin, displaying increasingly high
levels of resistance at the whole-genome level.
We followed the rapid rise of deltamethrin resistance
in the village of Vallée du Kou 7 (VK7) and collectedmosquitoes either exposed or non-exposed to delta-
methrin in 2011, 2012 and 2013 for transcriptional ana-
lysis against laboratory susceptible strains. Using a
filtering process based on the over-expression of candi-
dates in VK7, as well as an increase in expression from
2011 to 2012, we generated a list of candidate genes, in-
cluding well-studied detoxification enzymes, transporters
and cuticular genes that are likely contributing to the ex-
ceptionally strong pyrethroid resistance phenotype in this
population. The investigation also highlighted that target
site resistance, whilst highly prevalent, was not strongly
associated with survival after pyrethroid exposure.
Results
Deltamethrin resistance associated gene expression
Two whole-transcriptome microarray experiments were
performed on VK7 An. coluzzi collected as part of June
2011 and July 2012 bioassays (described in [5]) to iden-
tify candidate genes associated with deltamethrin resist-
ance. This included mosquitoes that had survived more
than 10 hours exposure to the diagnostic dose of pyre-
throids, an unprecedented high level of resistance for
malaria vectors. A detailed experimental design is given
in Figure 1. In 2012, we expanded the study to include a
second susceptible strain and an additional field strain
(Tengrela; TEN) with a less intense resistance phenotype
(~50% mortality to deltamethrin in a one-hour WHO
diagnostic dose test) to improve confidence in our can-
didate gene list. To identify candidate genes in VK7 we
made three underlying assumptions: a) candidate resist-
ance genes are more highly expressed in resistant field
populations versus susceptible lab colonies (MAL origin-
ating from Mali & NG originating from Cameroon), b)
the same underlying mechanisms were responsible for
resistance in 2011 and 2012 and c) genes conferring pyr-
ethroid resistance would be more highly over-expressed
in VK7 compared to TEN. A detailed analysis schema is
provided in Figure 2 and the Methods.
Genes over-expressed in resistant field populations
The filtering approach which compared all field resistant
populations to the susceptible laboratory strains, using
data from both 2011 and 2012, left 605 probes (repre-
senting 487 genes) (Additional file 1) including 15 cyto-
chrome P450s, 9 glutathione S-transferases (GSTs), 3
carboxylesterases and many other non–detoxification
genes. The top five over-expressed detoxification genes
based on the VK7/MAL comparison in 2012 included
GSTE2 (AGAP009194, four probes, average FC = 9.48),
CYP4G16 (AGAP001076, four transcripts, average FC =
6.30), GSTS1_1 (AGAP010404, three probes, average
FC = 3.7), CYP9J5 (AGAP012296, FC = 3.03) and CYP6P1
(AGAP002868, four probes, average FC = 2.69). The most
over-expressed non-detoxification genes consisted of an
2011 2012
Figure 1 Interwoven loop designs for microarray experiments performed in 2011 and 2012. In 2011, deltamethrin selected mosquitoes
from VK7 (VKR; LT50 = 254 min), unexposed mosquitoes from VK7 (VKC) and the Mali susceptible lab strain (MAL) were compared. In 2012, four
mosquitoes populations were compared including deltamethrin selected mosquitoes from VK7 (VKR; 600 mins exposure), unexposed mosquitoes
from a deltamethrin resistant population approximately 120 km from VK7, Tengrela (TEN), the susceptible MAL strain and a second fully susceptible lab
strain from N’Gousso, Cameroon (NG). The direction of the arrows represents a cy3 to cy5 hybridisation and three biological replicates were used for
each comparison.
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lase (AGAP009110, FC = 9.51), a cuticular protein with
chitin binding domains CPAP3-A1b (AGAP000987,
FC = 9.35) and a takeout protein associated with insect
circadian clocks (AGAP004262, FC = 11.48). Additional
over-expressed genes, which were also up-regulated in
later filtering steps (see below), included an aquaporin
(AGAP010326, FC = 7.97), chymotrypsin-1 (AGAP006709,
FC = 5.18) and the carboxylesterase, COEAE3G (AGAP
006724-RA, FC = 2.56, four probes) (Additional file 1).
Genes expressed at higher levels in deltamethrin
survivors from 2012 compared to 2011
Out of the 605 probes over-expressed in all the field re-
sistant populations compared to the laboratory suscep-
tible strains, 374 probes had a higher fold change in
2012 than in 2011 based on the VK7/MAL comparison
(Step E in Figure 2; Additional file 2). As resistance
levels increased dramatically between these years we
hypothesised that this probe list may include genes con-
tributing to the resistance phenotype. The five GSTs
genes (GSTE2 (AGAP009194, FC = 9.48), GSTMS3
(AGAP009946, FC = 2.52), GSTS1_2 (AF513639, FC =
2.42), GSTM1 (AGAP000165, FC = 2.24), and GSTE5
(AGAP009192, FC = 2.37)), five out the fifteen cyto-
chrome P450s (CYP4G16, CYP6P1, CYP9J5, CYP6Z3
(AGAP008217, FC = 2.36) and CYP9M1 (AGAP009363,FC = 2.27)) and two of out the three carboxylesterases
(COEAE3G (AGAP006724, FC = 2.41) and COEAE4G
(AGAP006725, FC = 1.37)) remained after this filtering
approach. The highest fold-change differences between
2012 and 2011 were observed for genes already showing
high constitutive expression including the chymotrypsin-
1 (AGAP006709, FC = 3.64), aquaporin (AGAP010326,
2.60), cuticular protein CPAP3-A1b (AGAP000987, FC =
2.19) and the ATP synthase (AGAP006879, FC differ-
ence = 2.14). The P450, CYP4G16 (AGAP001076), which
has been implicated in pyrethroid resistance elsewhere
[17], also showed an increase in expression in 2012.
Seven of the nine candidate genes chosen for qPCR
validation were expressed at higher levels in VK7 in 2012
compared to 2011 (two tailed t-test, P < 0.05) (Figure 3).
Genes expressed at higher levels in VK7 compared to TEN
We included An. coluzzi mosquitoes from Tengrela (TEN)
in the 2012 experiment to see whether a common set of
genes were up-regulated in pyrethroid resistant mosqui-
toes from VK7 and TEN. Considering that resistance is
higher in VK7 than TEN, we only retained probes sig-
nificantly over-expressed in VK7 compared to TEN. This
gave a final candidate gene list containing 157 probes
(Additional file 3). A hierarchical clustering analysis based
on the expression profiles of three comparisons between
VK7/MAL (2011), VK7/MAL (2012) and VK7/NG (2012)
Figure 2 Microarray data analysis schema showing the different steps and the number of probes obtained after each filtering step.
Each filtering step is based on our hypothesis of over-expression in field resistant populations compared to laboratory susceptible strains (steps A,
B and C), over-expression in VK7 compared to TEN (step D) and up-regulation in 2012 compared to 2011 according to the VK7-MAL comparison
(step E). The green and red arrows represent dye swaps between the samples.
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of the same gene and duplicate probes are removed, the
candidate gene list reduces further to 136 unique genes.
Several of the detoxification genes having higher FC in
2012, including CYP4G16, CYP9J5, CYP9M1, COEAE3G,
GSTE5, were retained in this list as well the components
of the cuticle (e.g. CPR 73, CPAPA3-A1a and CPAPA3-
A1b) and the chymotrypsin-1, aquaporin and ATP syn-
thase (Additional file 3).Genes expressed at higher levels in TEN compared to VK7
Interestingly, several detoxification genes were more
highly expressed in TEN than VK7 in 2012 (and thus
were filtered out of our final candidate list for VK7)
(Additional file 4). Of all genes up-regulated in TEN
(N = 171), the highest fold changes were for CYP6Z3
(AGAP008217, FC = 2.55, four probes) and CYP6P4
(AGAP002867, FC = 2.32). Both of these p450s also
showed a significant increase in basal expression in VK7
from 2012 to 2013 (Figure 3) suggesting that, given their re-
ported role in pyrethroid resistance [15,16], these enzymes
may be involved in resistance in both Tengrela and VK7.Target-site resistance
All three kdr mutations (L1014F, L1014S and N1575Y)
in the voltage gated sodium channel have been reported
in An. gambiae s.l from south-west Burkina Faso [3,19].
Dead and surviving VK7 mosquitoes after exposure to
the LT50 of deltamethrin were screened for each muta-
tion to determine whether, in addition to the increases
in gene expression described above, target-site resistance
contributes to the strong resistance phenotype. The
1014S kdr allele was not found in any sample. The
frequency of the 1014F allele in the 2011-2012 control
samples of An. coluzzi was high (0.823 to 0.880) but did
not differ significantly between date of collection (Fisher’s
exact test, two tailed P value > 0.05) (Table 1). A similar
frequency of 0.877 of 1014F was observed in 2012 from
Tengrela (Table 1). Samples collected in July 2013 from
the different breeding sites in VK7 and Tengrela showed
a similar frequency (chi-square test = 1.69, P = 0.43)
(Table 1). The 1575Y kdr allele had a frequency of
between 0.237 and 0.355 during the collection period in
both VK7 and Tengrela. No significant increase or de-
crease in the frequency of N1575Y was observed during
this time (Table 1).
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Figure 3 Relative mRNA levels of candidate resistance genes measured by qPCR. The level of expression was measured from An. coluzzi
from Vallée du Kou (2011, 2012, and 2013) and Tengrela (2012 and 2013) in samples independent to those used in the microarray experiments
and not exposed to insecticide. The relative values are presented according to the ddCt method [18] ± SEM of six biological replicates. A two-tailed
Student’s t-test was performed between the yearly values within population (log-scale). *= p < 0.05; n.s. = not significant.
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In almost all cases the frequencies of 1014F and 1575Y
were higher in mosquitoes surviving insecticide expos-
ure but the presence of the 1014F allele was only signifi-
cantly associated with deltamethrin survival in one
round (October 2011) (P = 0.04) and in the case of
1575Y, an association with deltamethrin survival was ob-
served in two rounds of collection (P = 0.015 and 0.043
in October 2011 and June 2012 respectively (Table 1)).
1575Y occurs exclusively on a haplotypic background of
1014F and a stronger association of the haplotype, rather
than single alleles, has been demonstrated for DDT and
pyrethroid resistance in some cases [19]. Haplotypic as-
sociation tests revealed that the presence of both 1014F
and 1575Y alleles increased the OR of surviving the del-
tamethrin LT50 in VK7 from all three collection rounds
but the difference was only significant for samples collected
in October 2011 and in June 2012 (OR 2.68 (P = 0.007)
and 3.00 (P = 0.046) respectively (Figure 5)).
Discussion
In this study, we applied a robust microarray-approach
to determine the transcriptional profile of an An. coluzzi
population undergoing further selection on top of analready strong pyrethroid resistance phenotype. We pre-
viously documented that deltamethrin resistance ratios
(the LT50 of the local resistant population divided by the
LT50 susceptible strain) increased from 54 to 730 in a
single calendar year from the village of VK7 in Burkina
Faso [5]. By analysing transcription levels of An. coluzzi
from VK7 in both 2011 and 2012, this provided a unique
opportunity to determine whether gene expression levels
were simultaneously rising with pyrethroid resistance in
a single wild-caught population of An. coluzzi from
south-west Burkina Faso.
Candidate genes for deltamethrin resistance in VK7
According to our hypotheses of over-expression in field
resistant mosquitoes compared to laboratory susceptible
strains, increased expression in VK7 from 2011 to 2012,
and finally, higher expression in VK7 than the more
moderate resistance phenotype displayed in nearby
Tengrela, we filtered microarray probes down to a final
list of 157 representing 136 genes which are potentially
contributing to deltamethrin resistance in VK7. These
encode enzymes and proteins with both detoxification
and non-detoxification functions. This gene list was
compared to data generated using the same microarray
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Figure 4 Hierarchial clustering analysis of the candidate probes for deltamethrin resistance over-expressed in An. coluzzi from VK7.
Clustering was performed using the Euclidean distance method on the 157 probes which were over-expressed in VK7 versus MAL in 2011 and
2012 as well as those over-expressed against NG. The colour scale represents the log fold change of VK7 against the susceptible strain.
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Table 1 The frequency of the L1014F and N1575Y mutations in An. coluzzii tested in deltamethrin resistance bioassays
Period Status L F n (alleles) (f) L1014F 95% CI N Y n (alleles) (f) N1575Y 95% CI
VK7
Jul-11 Control 22 102 124 0.823 0.744-0.886 80 44 124 0.355 0.276-0.442
Dead 23 97 120 0.808 0.728-0.870 92 34 126 0.270 0.200-0.354
Survivors 19 95 114 0.833 0.754-0.892 80 30 110 0.273 0.198-0.363
Oct-11 Control 27 163 190 0.858 0.801-0.901 134 56 190 0.295 0.234-0.363
Dead 42 194 236 0.822 0.768-0.866 174 60 234 0.256 0.205-0.316
Survivors 15 133 148 0.899* 0.839-0.939 91 55 146 0.377* 0.302-0.458
Jun-12 Control 25 183 208 0.880 0.828-0.918 151 55 206 0.267 0.211-0.331
Dead 9 45 54 0.833 0.710-0.912 42 12 54 0.222 0.131-0.351
Survivors 14 132 146 0.904 0.844-0.943 90 56 146 0.384* 0.309-0.465
Jul-13 Control 16 126 142 0.887 0.823-0.934 109 33 142 0.232 0.166-0.311
Tengrela
Jul-12 Control 14 100 114 0.877 0.803-0.931 87 27 114 0.237 0.162-0.326
Dead 18 80 98 0.816 0.725-0.887 66 32 98 0.327 0.235-0.429
Survivors 11 81 92 0.880 0.796-0.939 66 26 92 0.283 0.194-0.386
Jul-13 Control 24 124 148 0.838 0.768-0.893 109 39 148 0.264 0.194-0.342
Allele frequencies with 95% CI of 1014F and 1575Y kdr alleles in An. coluzzi from Tengrela and VK7. VK7 samples are stratified according to deltamethrin exposure
(unexposed control samples and mosquitoes that died or survived exposure to an approximate LT50). In Tengrela the exposure time was one hour. Sample sets
where allele frequency is significantly associated with insecticide survival (P <0.05) are marked by *.
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survivors of An. coluzzi from three independent sites in
Cote d’Ivoire, with the N’Gousso susceptible strain (C
Strode, unpublished data, ArrayExpress Accession num-
bers E-MTAB-3210, E-MTAB-3211, E-MTAB-3212).
One third of the 136 genes associated with deltamethrin
resistance in Burkina Faso were also found over ex-
pressed in all three populations from Côte d’Ivoire, in-
cluding CYP4G16 and the cuticular proteins CPAP3-A1a
and CPAP3-A1b (Additional file 5). This suggests that
similar mechanisms could underlie the pyrethroid resist-
ance that is spreading across Western Africa.
Three P450s were present in the list of VK7 candidate
probes (CYP4G16, CYP9J5, and CYP9M1). CYP4G16 is
becoming increasingly associated with pyrethroid resist-
ance with evidence for over-expression in another majorFigure 5 Haplotypic association tests for the three kdr haplotypes (10
An. coluzzi to deltamethrin LT50. Odds ratios (OR) are represented with t
direction of the OR calculation. *p < 0.05, **p < 0.01.vector of the An. gambiae complex, An. arabiensis [17,20].
Although CYP4G16 does not metabolize pyrethroids dir-
ectly, it may play a role in enhancing cuticular hydrocar-
bon synthesis as demonstrated in members of the CYP4G
family previously [21,22]. The presence of additional genes
with putative roles in cuticular hydrocarbon synthesis
(two elongases (AGAP003196-RA & AGAP013219-RA),
3-hydroxyacyl-coa dehydrogenase (AGAP013544-RA) and
fatty acyl-CoA elongase (AGAP003195-RA)) strengthens
the support for the involvement of this pathway, and
CYP4G16, in pyrethroid resistance in An. gambiae, al-
though further functional validation is needed. Further-
more, the Cuticular Proteins Analogous to Peritrophins
(CPAP) class of proteins are expressed in cuticule forming
tissues and maintain the structural integrity of the cuticle
[23]. Two members of the CPAP3 family were consistently14L-1575N, 1014F-1575N and 1014 F-1575Y) with survival of VK7
he level of significance and the arrows within the triangles show the
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and CPAP3-A1b AGAP000987-RA)). CPAP3-A1b was re-
cently over-expressed in An. gambiae from an agricultural
area in Northern Tanzania [24] and therefore this protein
class warrants further investigation as part of any cuticular
resistance hypothesis in this species.
The aquaporin (AGAP010326-RA) and chymotrypsin-
1 (AGAP006709-RA) were both significantly and highly
over-expressed in VK7. The precise role for these proteins
in insecticide resistance remains unclear. Aquaporins are
ubiquitous water transporting membrane proteins found
in the Malpighian tubule system of insects [25]. The aqua-
porin over-transcribed in this study was also the most
significantly and highly over-expressed gene in a genome-
wide transcriptional profile of an extremely resistant DDT
strain of An. coluzzi from Ghana (survival after 6 hr ex-
posure to DDT 4%) [10]. The presence of aquaporins in
the Malpighian tubules, which are also a potential site for
p450-mediated metabolism [26], may represent an efflux/
excretion system for insecticide detoxification. In the field
of drug resistance, the loss of the activity of one of these
transporters leads to resistance to melaminophenyl arsenic
(MPA) and pentamidine treatment in the African Tryp-
anosomiasis parasite (Trypanosoma brucei) [27]. Chymo-
trypsins are serine proteases secreted in the midgut of
insects [28]. Chymotrypsin transfected Culex pipiens
pallens cells treated with deltamethrin showed greater
viability compared to control cells [29] but it is not clear
how this enzyme class would directly or indirectly increase
insecticide tolerance.
Other metabolic enzymes were present in our VK7 can-
didate list including two carboxylesterases (COEAE3G,
COEAE4G) and a GST (GSTE5). The expression of two of
these genes, COEAE3G and GSTE5, was greater in VK7 in
2012 according to our qPCR assays. Although the up-
regulation of these enzymes has been shown in pyrethroid
and DDT resistant mosquito populations elsewhere
[12,13,30], it is more likely that these enzymes either play
a secondary role or are involved in resistance to other
compounds. For example, members of the epsilon class of
GSTs, and in particular GSTE2, can metabolise DDT [31]
and we included this in the qPCR assays given the strong
evidence in its role in DDT resistance and the elevated ex-
pression in the field An. coluzzi from VK7 and Tengrela.
The VK7 population displays intense DDT resistance with
50 hours of DDT exposure inducing only 34.3% of mortal-
ity (Toé et al, data not shown) and it is possible that
GSTE2 and/or GSTE5 are involved in resistance to DDT
rather than to pyrethroids [11,32].
As part of our filtering process to determine candidate
genes from VK7, we decided to choose only those genes
over-expressed in VK7 compared to Tengrela, however,
when analysing this data we noticed that two strong can-
didate P450s for pyrethroid resistance, CYP6Z3 andCYP6P4 [15,16], were more highly expressed in Tengrela
in 2012. However, by 2013, a year which saw pyrethroid
resistance ratios exceed 1000× in VK7 [5], the expres-
sion of these two P450s in VK7 increased significantly,
suggesting that these P450s may be contributing to the
resistance phenotype in both locations.
The vast majority of transcriptional studies investigat-
ing the association of gene expression with insecticide
resistance have focussed on the over-expression of
candidate genes. While there is a large body of evidence
to support this approach, the down-regulation of genes
as part of key biological pathways should not be ignored.
Additional file 6 provides a list of the 291 probes (254
genes) down-regulated in all resistant strains versus the
susceptible lab colonies including those under-transcribed
in VK7 compared to TEN. This list includes many
transporter proteins (including odorant binding proteins)
and ion channels plus a small number of cytochrome
P450 genes.
The 1014F-1575Y kdr haplotype only accounts for a small
portion of the resistance phenotype in VK7
The link between the kdr 1014F allele in the target
sodium channel and the ability to survive pyrethroids or
DDT is clear with selective sweeps acting upon this al-
lele throughout different parts of Africa [7]. However, it
is also evident that kdr alone does not account for all of
the phenotypic variation in resistance. In this study,
1014F or 1575Y alone were only mildly associated with
an increased ability to survive the LT50 for deltamethrin.
The 1014F kdr diagnostic might only have a limited im-
pact in populations with high levels of pyrethroid resist-
ance, as reported here, and elsewhere in West Africa
[33]. The N1575Y mutation is found exclusively on a
1014F haplotypic background and this haplotype has
been shown to confer additional selective advantage in
presence of insecticides [19]. The 1014F-1575Y haplotype
did provide some protection to deltamethrin (Figure 5)
but the highest OR observed of 3.00 does not account for
the extremely high resistance ratios observed in VK7.
Conclusions
Using a quantitative approach to resistance monitoring
we recently documented the highest level of deltameth-
rin resistance recorded in field-caught An. gambiae to
date. Transcriptional profiling of these resistant mosqui-
toes has identified a suite of candidate genes, which can
be used to monitor resistance levels as attempts are
made to mitigate against development of additional re-
sistance in the future using new vector control tools
[34]. Furthermore, the findings presented here provide
evidence for additional mechanisms which might be
contributing to such a strong phenotype (i.e. cuticular
synthesis) and urgently need further investigation.
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Mosquito collections and genotyping
All mosquitoes used for the genotyping and microarrays
were collected in June of 2011 and July of 2012 from
breeding sites as larvae and reared to adults at the insect-
aries of CNRFP. In 2013, these included adults emerging
from larvae collected in paddy fields and open puddles
and reared separately. Mosquitoes were collected from
two study sites of VK7 (11°39’N, 04°41’W) and Tengrela
(10°40’N, 4°50’W) where the level of insecticide resistance
has been characterised and its impact on LLIN efficacy re-
ported [5]. Prior to RNA extraction, two or three legs of
each individual mosquito taken from deltamethrin-treated
or non-treated bioassays were removed for PCR identifica-
tion and genotyping before placing the remaining body in
RNA later (Sigma). Genomic DNA was extracted from
mosquito legs by boiling in 20 μl 1× PCR buffer or from
whole mosquitoes using Livak buffer [35]. Identification of
species within the An. gambiae complex was performed
using SINE-PCR [36]. The frequencies of the 1014F,
1014S and 1575Y kdr mutations were assessed using
TaqMan® PCR assays [19,37]. Genotyping was performed
on all the control, surviving and dead mosquitoes exposed
to the LT50. Allele frequencies were compared between
dead and surviving insects using a 2×2 contingency table
(Fisher's exact test, two-tailed P-value). Haplotype asso-
ciation tests between 1014L-1575N, 1014F-1575N and
1014F-1575Y and survival to deltamethrin were per-
formed using the Haploview software v.4.2 [38] and the
odds ratio for survival and chi-square tests for association
conducted for each round of insecticide testing.
Whole genome microarray study design
All the mosquitoes used for microarrays and the qPCR
assays were confirmed as An. coluzzi (formerly An.
gambiae M molecular form) [39]. Two independent whole-
genome microarray experiments were performed to
identify candidate genes associated with deltamethrin re-
sistance in VK7 using an interwoven a loop design
(Figure 1) [40]. The interwoven loop design used in our ex-
periments has been shown to provide more power in de-
tecting small differences in gene expression [41]. The first
experiment compared VK7 mosquitoes collected in 2011
that were a) unexposed to insecticides (VKC) and b) had
survived a 4 hr exposure to 0.05% deltamethrin (VKR)
with an insecticide susceptible strain from Mali (MAL). In
the second experiment, VK7 mosquitoes collected in the
following summer in 2012 which had survived a 10 hr ex-
posure to deltamethrin (0.05%) (VKR) were compared to
MAL and a second fully susceptible strain from N’Gousso
(NG) (Cameroon). In this second experiment, an unex-
posed population from Tengrela (TEN), a rice field area lo-
cated approximately 120 km from VK7 which showed 50%
mortality following one hour exposure to deltamethrin,was added to the design. The objective of this expanded
study in 2012 was to improve the confidence in our candi-
date gene list by including a second susceptible strain and
an additional field strain with a less intense resistance
phenotype. Each biological replicate in the microarray
consisted of ten non-blood females and were 5 days old.
RNA extraction and microarray data analysis
Mosquitoes exposed to insecticide were retained for a fur-
ther 24 hours prior to storage in RNA later (Sigma) to
minimise any induction effect from insecticide exposure
and unexposed mosquitoes were exposed to untreated
control papers. Total RNA was extracted from pools of
ten mosquitoes using RNAqueous®-4PCR Kit for isolation
of DNAse-free RNA (Ambion) according to the manufac-
turer’s protocol. The quality and quantity of the RNA
used for the microarrays was assessed using a Nanodrop
spectrophotometer (Nanodrop Technologies) and 2100
Bioanalyser (Agilent Technologies). cRNA (100 ng) was
synthesised and labelled with cyanine 5 (cy5) or cyanine
3 (cy3) using the Two-Color Low Input Quick Amp
Labelling Kit (Agilent Technologies) according to the
manufacturer’s instructions. Labelled cRNA were then
column purified (QIAGEN) and eluted in 30 μl of RNase
free water. Labelled cRNA samples (300 ng) were hy-
bridized to the 8×15K Aligent whole-transcriptome An.
gambiae microarray chip (A-MEXP-2196) [10] for 17 h
at 65°C. Slide washing, scanning and feature extraction
were performed as described previously [10].
The raw array data were normalised using LIMMA
[42] prior to applying a MAANOVA model in R soft-
ware [43]. The 2011 and 2012 results were combined
and a hypothesis driven filtering approach of the probe
sets applied to identify candidate genes in VK7. A
schema of our approach is given in Figure 2. Under our
hypothesis of greater expression in resistant mosquitoes,
genes were considered candidates if probes were signifi-
cant (false discovery rate adjusted P value (q) < 0.05)
and the fold-changes were consistently up-regulated in
all pair-wise comparisons between resistant versus sus-
ceptible mosquitoes (Steps A-C, Figure 2). This provided
a set of baseline candidate probes from which probes were
filtered further if they were significantly over-expressed
(q < 0.05) in VK7 compared to TEN (Step D, Figure 2)
and showed greater expression in 2012 compared to
2011 (Step E, Figure 2).
qPCR for candidate gene expression in VK7 and TEN
The expression of a selection of nine genes from the micro-
array analyses was validated using reverse-transcription
quantitative PCR (RT-qPCR). All mosquito samples were
unexposed to insecticides. Each replicate was independent
of the samples used in the microarray to provide external
validation of the expression data. Our hypothesis was
Toé et al. BMC Genomics  (2015) 16:146 Page 10 of 11based on the rapid rise of resistance in VK7 during the time
period between June 2011 and July 2013 and therefore we
anticipated expression of candidates to concurrently rise.
According to this hypothesis we were concerned primarily
with the changes in expression levels in the resistant sites
rather than pair wise comparisons with susceptible strains.
As a result only samples from VK7 and Tengrela were
tested in the qPCR. Primers were designed using Primer-
BLAST tool (NCBI: http://www.ncbi.nlm.nih.gov/tools/
primer-blast/) against the An. gambiae PEST sequence and
at least two primer sets were used to assess their efficiency
and specificity by running a standard curve over a five-fold
serial dilution (Additional file 7). Approximately 600 ng of
RNA was reverse transcribed to first strand cDNA using
SuperScript™ III reverse transcriptase (Invitrogen). All six
biological replicates for each population were run in tripli-
cate using 5 μl of input cDNA diluted 10-fold, 2× SYBR
Brilliant III (Aligent Technologies) and 300 nM of the
forward and reverse primer on the Mx3005P qPCR system
(Aligent Technologies). The thermal profile for each reac-
tion was 95°C for 3 min followed by 40 cycles of 95°C for
10 s and 60°C for 10 s. The qPCR data were analysed
according to the ddCt method [18] relative to the average
of three housekeeping genes encoding a ubiquitin protein
(AGAP007927), an elongation factor (AGAP005128) and
the S7 ribosomal protein (AGAP010592). The qPCR effi-
ciency of each primer set was incorporated into the reac-
tion. The Ct data were log-transformed to ensure a normal
distribution of the data prior to statistical analysis. To deter-
mine whether a significant changes in expression levels
occurred during the timeframe of the study (in line with
increases in deltamethrin resistance), normalised mRNA
levels were compared between each time point for each
population separately using a two-tailed t-test (P <0.05).Supporting data
The data sets supporting the results of this article are in-
cluded within the article and as additional files. Micro-
array data are available in the ArrayExpress database
(www.ebi.ac.uk/arrayexpress) under accession numbers
E-MTAB-2859 and E-MTAB-2875.Additional files
Additional file 1: List of 605 probes up-regulated in field resistant
populations versus laboratory susceptible strains (steps A, B & C of
Figure 2 schema). Probes listed in order of fold change between the
VK7/MAL comparison in 2012 (highlighted in grey).
Additional file 2: List of 374 probes up-regulated in field resistant
populations versus laboratory susceptible strains and showing
higher expression in 2012 than 2011 (steps A, B, C & E of Figure 2
schema). Probes listed in order of fold change difference between the
VK7/MAL comparison in 2012 versus 2011 (highlighted in grey).Additional file 3: List of 157 candidate probes for deltamethrin
resistance in VK7. Probes listed in order of fold change between the
VK7/MAL comparison in 2012 (highlighted in grey).
Additional file 4: List of probes showing over-expression in Tengrela
compared to VK7 in 2012. Probes listed in order of fold change between
TEN versus VK7 in 2012 (highlighted in grey).
Additional file 5: Over-expressed genes from three populations of
An. coluzzi from Côte d’Ivoire associated with deltamethrin resistance
that are also up-regulated in VK7 in this study. The fold-changes for
three populations (Bouaké, M’Be and Tiassalé) compared to N’Gousso are
listed with the transcript ID and description.
Additional file 6: List of 271 probes significantly down-regulated in
resistant populations versus laboratory susceptible strains and
under-expressed in VK7 versus TEN. Probes listed in order of the most
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